Results aid decision-making about anticoagulant therapy
Alteration ‘opens the floodgates’ to DHT synthesis in prostate tumors
Survey sees disparate views of treatment value, burden
Symposium presenters offer practice-changing updates
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Comprehensive treatment and trial access show promise
Palliative Y90 treatment may get earlier application
Learn about featured clinical trials currently enrolling or search our trials database.
Heating tumor sensitizes cancer stem cells to radiation effects
Technology has therapeutic, diagnostic advantages
International effort allows experts to confer on complex cases
Advertisement
Advertisement